Medicine guide

GEFITINIB CIPLA

As listed in the register: GEFITINIB CIPLA 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

250 mg · comprimido recubierto con película

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Gefitinib
Made by
Cipla Europe

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL01EB01

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byCipla Europe
Active substanceGefitinib
Used inCancer treatments and immune-system medicines
Strength250 mg
Formcomprimido recubierto con película
ClassificationL01EB01 · Cancer treatments and immune-system medicines
Routevía oral
MarketedNo — authorised but not currently marketed, according to the register
GenericYes — a generic medicine, according to the register
Name in the registerGEFITINIB CIPLA 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Nº Registro84785

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician

Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.